StockData
Aurora Cannabis Inc logo

Aurora Cannabis Inc (ACB) company profile

ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 40-F on Jun 11, 2026Score 6/30
$4.61−0.33 (-6.68%)

Close on Nov 16, 2026Market cap $271.75MP/E –Yield –

About Aurora Cannabis

Medicinal Chemicals & Botanical Products, SIC 2833

Aurora Cannabis Inc. engages in the cultivation, processing, and distribution of cannabis and related products. The company focuses primarily on its cannabis segment, with additional historical operations involving plant propagation. Its core product portfolio includes dried cannabis flower and cannabis extracts, supported by specialized production and agricultural facilities. Aurora supplies patients seeking medical cannabis, consumers in adult-use markets, and authorized commercial distributors across various jurisdictions.

The company conducts business and maintains assets across multiple international regions, including Canada, Australia, New Zealand, and member countries of the European Union. Its operational footprint features specialized regional operating entities such as Aurora Deutschland GmbH and MedReleaf Australia, alongside designated production facilities like the Sky and Sun facilities. Aurora Cannabis has its country of domicile in Canada.

Summary of the business section of Aurora Cannabis's latest annual report, written by StockData.

Company profile

Company

Legal name
Aurora Cannabis Inc
Founded
2013
Headquarters
Edmonton, A0
Address
2207 90b Street Sw T6X 1V8
Phone
(604) 362-5207
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
March 31
Auditor
Ernst & Young LLP, Vancouver, Canada

Stock & identifiers

Ticker
ACB
Exchange
Nasdaq
IPO date
Jul 15, 2014
Shares outstanding
59M, Mar 31, 2026
Filer category
<br>Emerging growth company
Stock splits
1-for-10 reverse, Feb 20, 2024; 1-for-12.67 reverse, Sep 25, 2020; 1-for-12 reverse, May 11, 2020
SEC CIK
1683541
CUSIP
05156X850
ISIN
CA05156X8504
FIGI
BBG006SCSYG7
Share class FIGI
BBG001SV77D1
LEI
549300F6VHCLKCUWDT34
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Aurora Cannabis's leadership is listed in its proxy statement (Form DEF 14A).

Corporate history

Events identified from SEC filings

See a number that looks wrong?